Chapel Hill, NC, United States of America

Susan J Kelly

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Duke University, Mountain View Pharmaceuticals, Inc., Horizon Pharma Rheumatology LLC. Active years: 1995-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan J Kelly. Retrieved from https://idiyas.com/inventor/susan-j-kelly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 30.0

CIPO Patents = 3

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 279(Granted Patents)

Location History:

West Trenton, NJ (US) (1995)
Chapel Hill, NC (US) (2003 - 2018)

Company Filing History:

Mountain View Pharmaceuticals, Inc.

patents

1 out of 9

Horizon Pharma Rheumatology LLC

patents

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2018

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9885024 - PEG-urate oxidase conjugates and use thereof (2018-02-06),

2. 8921064 - Method for purifying urate oxidase tetramers and octamers (2014-12-30),

3. 8618267 - PEG-urate oxidase conjugates and use thereof (2013-12-31),

4. 8067553 - PEG-urate oxidase conjugates and use thereof (2011-11-29),

5. 7927852 - Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates (2011-04-19),

6. 7927589 - PEG-urate oxidase conjugates and use thereof (2011-04-19),

7. 7723089 - PEG-urate oxidase conjugates and use thereof (2010-05-25),

8. 7056713 - Urate oxidase (2006-06-06),

9. 6576235 - PEG-urate oxidase conjugates and use thereof (2003-06-10),

10. D363803 - Decorative light for patio umbrella (1995-10-31),

Title: The Innovations of Susan J Kelly

Introduction

Susan J Kelly is a prominent inventor based in Chapel Hill, NC (US). She has made significant contributions to the field of biochemistry, particularly in the development of innovative therapeutic solutions. With a total of 10 patents to her name, her work has had a substantial impact on medical treatments.

Latest Patents

Among her latest patents is the invention of PEG-urate oxidase conjugates and their use. This invention involves a naturally occurring or recombinant urate oxidase (uricase) that is covalently coupled to poly(ethylene glycol) (PEG). The conjugates are designed to be substantially non-immunogenic while retaining at least 75% of the uricolytic activity of the unmodified enzyme. Another notable patent is the method for purifying urate oxidase tetramers and octamers. This method ensures that the protein is essentially free of large aggregates, making it suitable for treating chronic conditions without inducing antibody formation.

Career Highlights

Throughout her career, Susan has worked with esteemed institutions such as Duke University and Mountain View Pharmaceuticals, Inc. Her research has focused on enhancing the efficacy and safety of therapeutic proteins, contributing to advancements in medical treatments.

Collaborations

Susan has collaborated with notable professionals in her field, including Michael S Hershfield and L David Williams. These collaborations have further enriched her research and innovations.

Conclusion

Susan J Kelly's contributions to biochemistry and her innovative patents highlight her role as a leading inventor in her field. Her work continues to influence the development of effective medical therapies.

Profile summary based on public USPTO records.